POTOMAC, Maryland – (COMMERCIAL THREAD) – India Globalization Capital, Inc. (NYSE AMERICAN: IGC) announces that during its annual meeting of shareholders scheduled and called on October 15, 2021, voting on all matters as disclosed in the definitive proxy on the form 14A filed with the SEC on September 15, 2021, were adopted. Only shareholders registered on the registration date of September 10, 2021 were entitled and invited to vote.

At the annual meeting the following proposals were approved: (i) the proposal to elect Mr. Richard Prins to the board of directors of the Company to serve as a class B director until the meeting annual shareholders’ meeting of 2024; (ii) the proposal to ratify Manohar Chowdhry & Associates (“MCA”) as an independent registered public accounting firm of the Company for fiscal year 2022; (iii) the grant of 3,500,000 common shares to be granted from time to time to current and new employees, advisers, directors and consultants of the Company by the board of directors, in accordance with certain metrics, including performance, ‘acquisition and incentive as set by the board of directors and / or the CEO; and (iv) the proposal to adjourn or postpone the annual meeting to a later date or dates, if necessary, to allow for a further solicitation and voting of proxies.

About the IGC

India Globalization Capital, Inc. (IGC) is committed to the development of cannabinoid-based therapies for indications such as Alzheimer’s disease and pain. It operates in two lines of business, infrastructure and life sciences, and is headquartered in Potomac, Maryland.

www.igcinc.us, www.igcpharma.com, Twitter @IGCIR.